Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Danielle Moncrieffe"'
Autor:
Huu Hien Huynh, Katrina Forrest, Jessica O Becker, Michelle A Emrick, Geoffrey D Miller, Danielle Moncrieffe, David A Cowan, Andreas Thomas, Mario Thevis, Michael J MacCoss, Ben Hoffstrom, Peter H Byers, Daniel Eichner, Andrew N Hoofnagle
Publikováno v:
Clinical chemistry. 68(10)
Background The development of analytical approaches to help reduce the risk of growth hormone (GH) doping is important to fair competition and the health of athletes. However, the reliable detection of GH use remains challenging. The identification o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30049b2d2472ee4114727d9128dc5837
https://pubmed.ncbi.nlm.nih.gov/35906802
https://pubmed.ncbi.nlm.nih.gov/35906802
Autor:
Danielle Moncrieffe
Publikováno v:
Bioanalysis. 12:711-714
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57b3847526d7f80c80cc86679394c6b5
https://doi.org/10.4155/bio-2020-0042
https://doi.org/10.4155/bio-2020-0042
Autor:
Danielle Moncrieffe, David A. Cowan
Publikováno v:
Drug testing and analysis. 14(5)
The acceptance in 2012 by the World Anti-Doping Agency (WADA) of the biomarker test for human growth hormone (hGH) based on procollagen type III amino-terminal propeptide (P-III-NP) and insulin-like growth factor I (IGF-I) was perhaps the first time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2cbbe89fec5771b01689e7f24c968a1
https://pubmed.ncbi.nlm.nih.gov/34418311
https://pubmed.ncbi.nlm.nih.gov/34418311
Autor:
Ashley E. Ross, Sumit Kar, Danielle Moncrieffe, Chris Williams, Sooraj Baijnath, Omar S. Barnaby
Publikováno v:
Bioanalysis. 12(12)
Over the past 10 years, Bioanalysis and Bioanalysis Zone have been proud to host the Bioanalysis Rising Star Award (formerly the New Investigator Award), to recognize and showcase the most promising early-career scientists in our community. The time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d9cacf76baf05e1e27b96e360dc665
https://pubmed.ncbi.nlm.nih.gov/32618474
https://pubmed.ncbi.nlm.nih.gov/32618474
Autor:
Andrew N Hoofnagle, David A Cowan, Larry D Bowers, Mario Thevis, Brian Ahrens, Daniel Eichner, Andreas Thomas, Jessica O Becker, Samantha Carletta, Holly D Cox, Danielle Moncrieffe
Publikováno v:
Clinical chemistry. 66(4)
Background Insulin-like growth factor-I (IGF-1) is measured mainly by immunoassay for the diagnosis and treatment of growth hormone (GH) disorders, and to detect misuse of GH in sport. Immunoassays often have insufficient inter-laboratory agreement,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fb644d1d668893a30b0ef40f4e516eb
https://pubmed.ncbi.nlm.nih.gov/32232452
https://pubmed.ncbi.nlm.nih.gov/32232452
Publikováno v:
Moncrieffe, D, Parkin, M C & Cowan, D A 2018, ' Peptide selection for the quantification of P-III-NP in human serum by mass spectrometry ', Rapid Communications in Mass Spectrometry, vol. 32, no. 7, pp. 535-542 . https://doi.org/10.1002/rcm.8066
Rationale: Procollagen III amino-terminal propeptide (P-III-NP) is currently monitored in human doping control as a biomarker for growth hormone administration and also in clinical diagnostics using immunoassays. Drawbacks to this approach have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::507ecc2d99f637b54b42b9a32f6c8ccb
https://kclpure.kcl.ac.uk/ws/files/92471132/Peptide_selection_for_the_MONCRIEFFE_Accepted10January2018_GREEN_AAM.pdf
https://kclpure.kcl.ac.uk/ws/files/92471132/Peptide_selection_for_the_MONCRIEFFE_Accepted10January2018_GREEN_AAM.pdf
